文献速递糖尿病

1型糖尿病儿童经历青春期期间使用混合闭环系统持续3年改善血糖控制

Sustained 3-Year Improvement of Glucose Control With Hybrid Closed Loop in Children With Type 1 Diabetes While Going Through Puberty.
PubMed 文献 · Diabetes Care · 2024-01-01

这项前瞻性多中心扩展研究随访了117例完成FLKAP试验的青春期前1型糖尿病儿童,评估长期使用混合闭环(HCL)系统对血糖控制和BMI的影响。结果显示HbA1c改善在30个月扩展期内持续维持,进入青春期与未进入青春期儿童间无差异,BMI z评分保持稳定,无严重低血糖发生。

要点

  • HCL扩展治疗30个月期间HbA1c改善持续维持,M9中位数7.0%与M39中位数7.0%相比非劣效检验P<0.0001。
  • M24时进入青春期(Tanner分期≥2,占54%)与仍处于青春期前儿童的HbA1c无差异。
  • BMI z评分保持稳定,M9为0.41、M24为0.48,非劣效检验P<0.0001;无严重低血糖,发生1例与HCL系统无关的酮症酸中毒。

核心结论

  • 长期使用HCL可安全有效地减轻1型糖尿病儿童青春期进展通常伴随的血糖控制恶化,且不影响BMI。

研究设计与样本

  • 前瞻性多中心扩展研究,随访Free-Life Kid AP(FLKAP)HCL试验,该试验纳入119例青春期前1型糖尿病儿童(年龄6-12岁)。
  • 扩展研究期间参与者可继续使用HCL共30个月(M9至M39);HbA1c每3个月收集至M39,连续血糖监测指标、BMI z评分和Tanner分期收集至M24;采用非劣效性检验评估参数随时间的可持续性。
  • 117例儿童完成扩展研究,开始扩展研究时平均年龄10.1岁(最小至最大6.8-14.0岁)。

主要发现

  • FLKAP试验中获得的HbA1c改善在扩展研究期间显著持续(中位数[四分位距],M9为7.0%[6.8-7.4],M39为7.0%[6.6-7.4],非劣效性检验P<0.0001)。
  • HbA1c在M24时进入青春期(Tanner分期≥2,占54%的患者)的儿童与仍处于青春期前的患者之间无差异。
  • BMI z评分保持稳定(M9为0.41[-0.29至1.13],M24为0.48[-0.11至1.13],非劣效性检验P<0.0001)。
  • 无严重低血糖发生,发生1例与HCL系统无关的酮症酸中毒。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the impact of prolonged hybrid closed loop (HCL) use in children with type 1 diabetes (T1D) on glucose control and BMI throughout pubertal progression. RESEARCH DESIGN AND METHODS: We used a prospective multicenter extension study following the Free-Life Kid AP (FLKAP) HCL trial. The 9-month previously reported FLKAP trial included 119 prepubertal children (aged 6-12 years). During the extension study, participants could continue to use HCL for 30 months (M9 to M39). HbA1c values were collected every 3 months up to M39, while continuous glucose monitoring metrics, BMI z scores, and Tanner stages were collected up to M24. Noninferiority tests were performed to assess parameter sustainability over time. RESULTS: One hundred seventeen children completed the extension study, with mean age 10.1 years (minimum to maximum, 6.8-14.0) at the beginning. Improvement of HbA1c obtained in the FLKAP trial was significantly sustained during extension (median [interquartile range], M9 7.0% [6.8-7.4], and M39 7.0% [6.6-7.4], P < 0.0001 for noninferiority test) and did not differ between children who entered puberty at M24 (Tanner stage ≥2; 54% of the patients) and patients who remained prepubertal. BMI z score also remained stable (M9 0.41 [-0.29 to 1.13] and M24 0.48 [-0.11 to 1.13], P < 0.0001, for noninferiority test). No severe hypoglycemia and one ketoacidosis episode not related to the HCL system occurred. CONCLUSIONS: Prolonged use of HCL can safely and effectively mitigate impairment of glucose control usually associated with pubertal progression without impact on BMI in children with T1D.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Bismuth É, Tubiana-Rufi N, Rynders CA, et al. Sustained 3-Year Improvement of Glucose Control With Hybrid Closed Loop in Children With Type 1 Diabetes While Going Through Puberty. Diabetes Care. 2024. PMID: 38985499. doi:10.2337/dc24-0916

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。